Physician

Abdallah Khourdaji, MD

According to 2025 Medicare claims, Abdallah Khourdaji, MD (NPI: 1093799652) practices dermatology in the Stockton-Lodi, CA market, with the plurality of this provider's patient population coming from San Joaquin, CA. This provider's primary affiliated billing organization is GOLDEN STATE DERMATOLOGY ASSOCIATES, INC. (NPI: 1700860871; TIN: 68-0299684) and primary practice location at 95242-7501.

Khourdaji's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 852 traditional Medicare patients, billed 7,012 HCPCS/CPT codes, and received $649,696 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,002 prescription claims across 326 beneficiaries totaling $1,308,562 in drug costs, led by Tremfya (Guselkumab). Open Payments data shows 72 records totaling $1,141. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $451,937 to $649,696. Similarly, Part D prescription costs have risen steadily, from $749,931 to $1,308,562. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$558K$1.1M2015 Medicare payment: $451,937 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $427,697 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $439,548 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $839,125 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,116,692 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $876,234 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $914,733 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $697,344 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $652,669 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $649,696 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,28510,912$451,937
20161,2809,657$427,697
20171,2708,811$439,548
20181,66111,534$839,125
20191,88013,187$1,116,692
20201,5019,616$876,234
20211,56510,547$914,733
20221,0237,709$697,344
20238857,045$652,669
20248527,012$649,696

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$821K$1.6M2015 Drug cost: $749,931 (USD; Tot_Drug_Cst)2016 Drug cost: $1,226,407 (USD; Tot_Drug_Cst)2017 Drug cost: $1,030,062 (USD; Tot_Drug_Cst)2018 Drug cost: $1,117,683 (USD; Tot_Drug_Cst)2019 Drug cost: $1,232,541 (USD; Tot_Drug_Cst)2020 Drug cost: $1,094,461 (USD; Tot_Drug_Cst)2021 Drug cost: $1,136,039 (USD; Tot_Drug_Cst)2022 Drug cost: $1,641,536 (USD; Tot_Drug_Cst)2023 Drug cost: $1,627,463 (USD; Tot_Drug_Cst)2024 Drug cost: $1,308,562 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154401,552$749,931
20164591,716$1,226,407
20174641,691$1,030,062
20184831,703$1,117,683
20194331,408$1,232,541
20203221,081$1,094,461
20213561,120$1,136,039
20223691,287$1,641,536
20233451,032$1,627,463
20243261,002$1,308,562

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth270335$80
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5931,007$70
17000Destruction of precancer skin growth, 1 growth443694$44
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more294397$44
17003Destruction of precancer skin growth, 2-14 growths3532,277$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TremfyaGuselkumab181,008$246,968
Humira PenAdalimumab17484$221,742
Dupixent PenDupilumab22602$80,201
OtezlaApremilast18540$79,994
FluocinonideFluocinonide1013,125$5,051

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.72$1,141ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdallah Khourdaji, MD?

Tedicare shows public-source Medicare data for Abdallah Khourdaji, MD (NPI 1093799652), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdallah Khourdaji, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdallah Khourdaji, MD?

Abdallah Khourdaji, MD is linked to GOLDEN STATE DERMATOLOGY ASSOCIATES, INC. (billing NPI 1700860871) in the available physician profile data.

Does Abdallah Khourdaji, MD have Open Payments data?

Abdallah Khourdaji, MD has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.